An Open Randomized Dose Selection Study Evaluating the Safety, Immunogenicity, and Impact of a TB Vaccine, MVA85A, on the Immunogenicity of EPI Vaccines Administered Simultaneously to Healthy Infants Previously Vaccinated With BCG.
Phase of Trial: Phase I
Latest Information Update: 16 Feb 2010
At a glance
- Drugs Hepatitis B vaccine recombinant; Hib-DTP vaccine; MVA 85A
- Indications Tuberculosis
- Focus Adverse reactions; Pharmacodynamics
- 16 Feb 2010 Actual patient number (214) added as reported by ClinicalTrials.gov.
- 16 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Sep 2009 Planned end date changed from 1 Jul 2008 to 1 Dec 2009 as reported by ClinicalTrials.gov.